Jain, N. A., Lu, K., Ito, S., Muranski, P., Hourigan, C. S., Haggerty, J., . . . Barrett, A. J. (2014). The Clinical and Financial Burden of Preemptive Management of CMV Disease after Allogeneic Stem Cell Transplantation – Implications for Preventative Treatment Approaches.
Παραπομπή Chicago StyleJain, Natasha A., et al. The Clinical and Financial Burden of Preemptive Management of CMV Disease After Allogeneic Stem Cell Transplantation – Implications for Preventative Treatment Approaches. 2014.
Παραπομπή MLAJain, Natasha A., et al. The Clinical and Financial Burden of Preemptive Management of CMV Disease After Allogeneic Stem Cell Transplantation – Implications for Preventative Treatment Approaches. 2014.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.